About Medicenna Therapeutics Corp - Company Information, Overview, History and Profile
What does Medicenna Therapeutics Corp do?
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
Medicenna Therapeutics Corp Management structure
All Gross Remunerations are in USD
Medicenna Therapeutics Corp Board of directors
All Gross Remunerations are in USD